NCT05361759

Brief Summary

The National Tunisian Registry of Cardiac Implantable Electronic Devices is an observational, prospective and multicenter study aiming to assess the epidemiological, clinical and therapeutic profile of cardiac implantable electronic Devices in Tunisia. Cardiologists from both sectors (public and private) are participating in the study, with 26 investigational centers. Data is captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) \& ICH (International Conference on Harmonisation) requirements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,518

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 5, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

2.6 years

First QC Date

April 30, 2022

Last Update Submit

August 14, 2023

Conditions

Keywords

Cardiac Implantable Electronic DevicesHeartPacemakerImplantable Cardioverter DefibrillatorCardiac Loop RecordersBiventricular PacemakersHeart rhythm disorder

Outcome Measures

Primary Outcomes (1)

  • Incidence of patients undergoing cardiac implantable electronic devices in Tunisia

    Number of subjects with heart disease (heart failure, rythm disorder) and willing to participate at the study and who are eligible for cardiac implantable electronic devices procedures

    at inclusion

Secondary Outcomes (1)

  • Heart complication

    at 12 months of follow-up

Interventions

Description of Cardiac Implantable Electronic Devices

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing cardiac implantable electronic device procedure

You may qualify if:

  • Patients originated from Tunisia
  • Signed informed consent
  • Patients undergoing a cardiac implantable electronic device procedure

You may not qualify if:

  • Informed Consent not given

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Tunisian Society of Cardiology and CardioVascular Surgery

Tunis, 1053, Tunisia

Location

Related Publications (1)

  • Chabrak S, Haggui A, Allouche E, Ouali S, Ben Halima A, Kacem S, Krichen S, Marrakchi S, Fehri W, Mourali MS, Jabbari Z, Ben Halima M, Neffati E, Heraiech A, Slim M, Kachboura S, Gamra H, Hassine M, Kraiem S, Kammoun S, Bezdah L, Jridi G, Bouraoui H, Kammoun S, Hammami R, Chettaoui R, Ben Ameur Y, Azaiez F, Tlili R, Battikh K, Ben Slima H, Chrigui R, Fazaa S, Sanaa I, Ellouz Y, Mosrati M, Milouchi S, Jarmouni S, Ayadi W, Akrout M, Razgallah R, Neffati W, Drissa M, Charfeddine S, Abdessalem S, Abid L, Zakhama L. National Tunisian Study of Cardiac Implantable Electronic Devices: Design and Protocol for a Nationwide Multicenter Prospective Observational Study. JMIR Res Protoc. 2024 Apr 8;13:e47525. doi: 10.2196/47525.

Related Links

Study Officials

  • Sonia Chabrak, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    STUDY CHAIR
  • Abdeddayem Haggui, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    STUDY DIRECTOR
  • Salma Krichène, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    PRINCIPAL INVESTIGATOR
  • Slim Kacem, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    PRINCIPAL INVESTIGATOR
  • Sonia Marrakchi, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    PRINCIPAL INVESTIGATOR
  • Emna Allouche, MD

    Tunisian Society of Cardiology and Cardiovascular Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2022

First Posted

May 5, 2022

Study Start

January 18, 2021

Primary Completion

August 15, 2023

Study Completion

August 15, 2023

Last Updated

August 15, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations